NewsScan
A Daily Summary of Healthcare and Business News
11/22/2021 - The Associated Press by: John Raby
CHARLESTON, WV - A West Virginia nonprofit group said Friday that it is offering $1 million in grants to boost COVID-19 testing and vaccination efforts and address HIV and other health issues in the state's most rural and at-risk communities.
A subscription may be necessary to view this article.
11/22/2021 - The Associated Press by: Lauran Neegaard, Matthew Perrone and Mike Stobbe
WASHINGTON, DC - The U.S. on Friday opened COVID-19 booster shots to all adults and took the extra step of urging people 50 and older to seek one, aiming to ward off a winter surge as coronavirus cases rise even before millions of Americans travel for the holidays.
A subscription may be necessary to view this article.
11/22/2021 - Charleston Gazette-Mail
CHARLESTON, WV - Active COVID-19 cases surpassed the 7,000 mark on Friday for the first time this month, with a total of 7,275 active cases.
A subscription may be necessary to view this article.
11/22/2021 - The Herald-Dispatch by: Fred Pace
HUNTINGTON, WV - The U.S. Nuclear Regulatory Commission (NRC) has issued a confirmatory action letter to Cabell Huntington Hospital documenting a series of corrective actions it has agreed to carry out in response to a potential overexposure to radiation involving a physician.
A subscription may be necessary to view this article.
11/22/2021 - The Exponent Telegram by: Christopher E. Mascio
MORGANTOWN, WV - Congenital heart disease is the most common birth defect.
A subscription may be necessary to view this article.
11/19/2021 - The Hill by: Justine Coleman
WASHINGTON, DC - A new analysis estimates that hospital strain during the pandemic is linked to thousands of ensuing excess deaths, signaling the significance of ensuring hospitals do not reach full capacity amid COVID-19 surges.
A subscription may be necessary to view this article.
11/19/2021 - The Associated Press
WASHINGTON, DC - The U.S. government will pay drugmaker Pfizer $5.29 billion for 10 million treatment courses of its potential COVID-19 treatment if regulators authorize it, the nation's largest purchase agreement yet for a coronavirus therapy.
A subscription may be necessary to view this article.